Authors:
Delsing, DJM
Offerman, EH
van Duyvenvoorde, W
van der Boom, H
de Wit, ECM
Gijbels, MJJ
van der Laarse, A
Jukema, JW
Havekes, LM
Princen, HMG
Citation: Djm. Delsing et al., Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE3-Leiden mice, CIRCULATION, 103(13), 2001, pp. 1778-1786
Authors:
Gijbels, MJJ
Elliott, GR
HogenEsch, H
Zurcher, C
van den Hoven, A
Bruijnzeel, PLB
Citation: Mjj. Gijbels et al., Therapeutic interventions in mice with chronic proliferative dermatitis (cpdm/cpdm), EXP DERMATO, 9(5), 2000, pp. 351-358
Authors:
de Winther, MPJ
Gijbels, MJJ
Van Dijk, KW
Havekes, LM
Hofker, MH
Citation: Mpj. De Winther et al., Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis, INT J TISS, 22(2-3), 2000, pp. 85-91
Authors:
de Winther, MPJ
van Dijk, KW
van Vlijmen, BJM
Gijbels, MJJ
Heus, JJ
Wijers, ER
van den Bos, AC
Breuer, M
Frants, RR
Havekes, LM
Hofker, MH
Citation: Mpj. De Winther et al., Macrophage specific overexpression of the human macrophage scavenger receptor in transgenic mice, using a 180-kb yeast artificial chromosome, leads to enhanced foam cell formation of isolated peritoneal macrophages, ATHEROSCLER, 147(2), 1999, pp. 339-347
Authors:
de Winther, MPJ
Gijbels, MJJ
van Dijk, KW
van Gorp, PJJ
Suzuki, H
Kodama, T
Frants, RR
Havekes, LM
Hofker, MH
Citation: Mpj. De Winther et al., Scavenger receptor deficiency leads to more complex atherosclerotic lesions in APOE3Leiden transgenic mice, ATHEROSCLER, 144(2), 1999, pp. 315-321
Authors:
Gijbels, MJJ
van der Cammen, M
van der Laan, LJW
Emeis, JJ
Havekes, LM
Hofker, MH
Kraal, G
Citation: Mjj. Gijbels et al., Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study, ATHEROSCLER, 143(1), 1999, pp. 15-25